Avicennia marina

What's the taxonomical classification of Avicennia marina?

Avicennia marina belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this lineage, it is categorized under the class Equisetopsida and the subclass Magnoliidae. Moving down the taxonomic hierarchy, it falls under the order Lamiales and is a member of the family Acanthaceae. Finally, the plant is identified by its specific genus, Aviценnia, and its species designation, marina.

Taxonomic Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Lamiales
Family Acanthaceae
Genus Avicennia
Species marina
Evidence Level: ★★★★☆

What are the morphological characteristics of this plant?

Avicennia marina has small, elliptical to lanceolate leaves that are opposite or sub-opposite, ranging from 2 to 7 centimeters in length, and possess a distinct grayish-green color with a salty texture. The plant is a woody shrub or tree characterized by a complex branching system and a rugged bark texture. To manage high salinity, it utilizes specialized salt glands on its leaf surfaces to excrete excess salt crystals. It also develops pneumatophores, which are pencil-like aerial roots that grow upward from the anaerobic mud to facilitate gas exchange. These morphological adaptations allow the species to thrive in harsh intertidal environments.

Evidence Level: ★☆☆☆☆

What is the geographical distribution of this plant?

This plant is distributed across the tropical and subtropical coastlines of the Indo-West Pacific, ranging from the East African coast through Southeast Asia to the western Pacific islands. It commonly inhabits intertidal zones and mangrove swamps where saline conditions are prevalent. Its range extends north toward southern Japan and south to the coasts of Australia and New Zealand. These plants thrive in muddy or sandy substrates along tropical shorelines worldwide. Through seed dispersal by ocean currents, the species successfully colonizes distant archipelagos and coastal estuaries.

Evidence Level: ★☆☆☆☆

How is this plant cultivated?

This plant Avicennia marina is cultivated in intertidal zones and coastal salt marshes where it can tolerate high salinity and periodic flooding.

Growers typically select low-lying areas with fine-grained, anaerobic sediments that allow for root stability. Successful establishment requires monitoring the tidal inundation levels to ensure the seedlings receive adequate moisture without complete desiccation. Propagation is often achieved through direct seed sowing or through the use of propagules collected from mature mangrove stands.

Maintaining proper water salinity and managing local sediment accumulation are critical factors for long-term survival in restoration projects.

Evidence Level: ★☆☆☆☆

What parts of this plant are used medicinally?

This plant Avicennia marina provides medicinal benefits through its bark, fruit, leaves, pneumatophores, and roots. The bark is often utilized for its various bioactive compounds that can aid in healing processes. Extracts from the leaves and fruit are frequently employed to treat different ailments due to their antioxidant properties. Even the specialized pneumatophores and the root system contribute to the plant's pharmacological potential in traditional practices. These diverse components work together to provide a wide range of therapeutic applications.

According to a study published by "Indian journal of pharmaceutical sciences", the leaves and bark of Avicennia marina were evaluated for antibacterial activity against Staphylococcus aureus and Proteus sp. The plant gave the best inhibition for these bacterial species and was selected for further investigations. Phytochemical screening of the leaf extracts of A. marina revealed the presence of alkaloids, steroids, triterpenoids, and flavonoids. However, the extracts did not indicate the presence of saponins and cardiac glycosides. Charcoal treated plant extracts of A. marina were able to inhibit both bacterial strains more than those of untreated plant extracts.

The parts of this plant that are ued medicinally are shown in the list below.

  • bark
  • fruit
  • leaf
  • pneumatophore
  • root
Evidence Level: ★★★☆☆

What traditional systems uses this plant?

This plant Avicennia marina has been utilized in Persian Folk Medicine for centuries to treat various ailments through its diverse biological properties. Local healers historically applied parts of the mangrove to address skin conditions and promote wound healing. In many coastal regions, the plant's extracts were also used to manage digestive issues and inflammatory responses. Its historical role extends to providing medicinal resources for populations living in salt-marsh environments. These traditional practices highlight the plant's long-standing importance in regional ethnobotanical knowledge.

According to a study published by "Iranian journal of pharmaceutical research : IJPR", Avicennia marina is a species of mangrove tree used for the treatment of small pox lesions in Persian folk medicine. The methanol extract of this plant showed the highest antiviral activity, specifically with its most polar fraction, fraction D, inhibiting HSV with TI and SI values of 57.1 and 133. This same fraction D showed mild activity against HIV with an SI value of 6.25 in fraction 3. Phytochemical investigation revealed that fraction D encompasses flavonoids compounds. This fraction was found to be able to inhibit replication of HSV after entry but did not show significant potency against HIV-1.

The hystorical systems that uses this plant are shown in the list below.

  • Persian Folk Medicine
Evidence Level: ★★★☆☆

What are the pharmacological activities of Avicennia marina?

This plant has antimicrobial, antioxidant, antibacterial, antifungal, and anti-inflammatory pharmacological activities derived from its rich secondary metabolites. The antioxidant properties help neutralize free radicals, which protects cells from oxidative stress and damage. Its broad antimicrobial profile includes significant antibacterial and antifungal capabilities that inhibit the growth of various pathogenic microorganisms. Additionally, the plant exhibits anti-inflammatory effects that can assist in reducing swelling and pain in biological tissues. These diverse medicinal attributes make Avicennia marina a subject of great interest for pharmaceutical research.

According to a study published by "BMC complementary and alternative medicine", Avicennia marina (Qurm) was one of seven different plants ground and extracted with ethanol. The ethanol extracts were evaporated and the residual extract dissolved in water prior to testing against Candida albicans in its different morphologies. The antibacterial and cytotoxic effects of the plant extracts were also tested. Out of the seven tested plants, Avicennia marina was included in the assessment for its potential medicinal properties.

The primary pharmacological activities of this plant are shown in the list below.

  • antibacterial
  • anticauncer
  • antioxidant
  • antimicrobial
  • antiviral
Evidence Level: ★★★☆☆

What medicinal compounds this plant contains?

This plant contains the specific medicinal compounds avicenol A, avicenol C, avicequinone A, avicequinone C, and avicennone A. These bioactive molecules are secondary metabolites derived from the Avicennia marina species. Researchers study these chemical constituents to explore their potential therapeutic properties in pharmacology. Each of these unique compounds contributes to the diverse chemical profile of the mangrove. Understanding their structure helps scientists identify how the plant interacts with various biological systems.

According to a study published by "Journal of natural products", seven new naphthoquinone derivatives were isolated from the twigs of Avicennia marina, including avicennone A (1), avicennone B (2), avicennone C (3), avicennone D (4), avicenone E (5), avicennone F (6), and avicennone G (7). The isolation also yielded known compounds avicequinone A (8), stenocarpoquinone B (9), avicequinone C (10), avicenol A (11), and avicenol C (12). Compounds 8-10 and a mixture of 4 and 5 all contain a 4,9-dione group. These specific components showed strong antiproliferative and moderate cytotoxic activities, along with antibacterial effects.

The primary medicinal compounds of this plant are shown in the list below.

  • avicenol A
  • avicenol C
  • avicequinone A
  • avicequinone C
  • avicennone A
Evidence Level: ★★★☆☆

What health conditions is this plant used for?

This plant is used for treating inflammation, cancer, breast cancer, tumors, and kidney diseases. Researchers have investigated its bioactive compounds for their potential to inhibit the growth of various malignant cells. Specifically, studies suggest that extracts from the plant may play a role in managing breast cancer and reducing the size of tumors. Its anti-inflammatory properties are also leveraged to mitigate systemic swelling and discomfort. Additionally, the plant shows promise in supporting renal health and addressing certain kidney diseases.

According to a study published by "Journal of nephropathology", the hydro-alcoholic extract of Avicennia marina leaves is investigated for its effect in the treatment of renal toxicity induced by carbon tetrachloride. The study involved 42 male rats divided into 6 groups, with n = 7 in each group. To address toxicity, the extract was administered at doses of 200 mg/kg, 400 mg/kg, or 800 mg/kg per day for 96 hours. Treatment with the extract caused a significant (P < 0.05) decrease in serum levels of lactate dehydrogenase and liver enzymes like AST, ALT, and ALP. Furthermore, the extract reduced necrosis and inflammation in renal tissue sections while improving renal tubules.

The main health conditions this plant is used for are shown in the list below.

  • cancer
  • inflammation
  • antimicrobial activity
  • antioxidant activity
  • tumor
Evidence Level: ★★★☆☆

What are the herbal preparations of this plant?

This plant is Avicennia marina, a mangrove species used to create medicinal herbal preparations such as aqueous extracts and chloroform extracts for various therapeutic purposes. The aqueous extract is commonly prepared by boiling the plant parts in water to release water-soluble bioactive compounds. In contrast, chloroform extracts are used to isolate more lipophilic constituents that may possess distinct pharmacological properties. These different preparation methods allow researchers to target specific chemical profiles within the plant's tissues. Scientific studies often evaluate these extracts for their antioxidant, antimicrobial, and anti-inflammatory potential.

According to a study published by "Phytotherapy research : PTR", aqueous crude extracts of the aerial parts of Avicennia marina exhibited moderate antifungal activity. Ethanol and butanol crude extracts of the plant showed an improved antimicrobial activity. Specifically, the butanol extract of Avicennia marina exhibited the highest activity when compared with the standard antibiotics tested. The butanol extracts at 2000 microg/disc of Avicennia marina demonstrated very good antibacterial activity against both gram-positive and -negative bacteria. These extracts also showed moderate to good antifungal activity against C. albicans and A. flavus.

The main herbal preparations of this plant are shown in the list below.

  • aqueous extract
  • chloroform extracts
Evidence Level: ★★★☆☆

What side effects this plant can have?

This plant can cause physiological complications including decreased plasma glucose concentration, increased alanine aminotransferase activity, medullary haemorrhage, monocellular infiltrations, and reduced body weight. These toxic effects often manifest after the consumption of excessive amounts of the plant extract. The disruption of glucose levels and liver enzyme activities indicates significant metabolic and hepatic distress. Furthermore, the presence of medullary haemorrhage and monocellular infiltrations suggests serious damage to internal tissues and inflammatory responses. Ultimately, the cumulative impact of these toxicities frequently leads to a noticeable reduction in overall body weight.

According to a study published by "Journal of applied toxicology : JAT", oral doses of 1 or 4 g kg(-1) for 3 consecutive days or 0.5 g kg(-1) day(-1) for 28 consecutive days were tested on rats. At a dose of 4 g kg(-1), the extract reduced both body and liver weights, whereas a dose of 1 g kg(-1) did not affect them significantly. The extract at both doses significantly increased leucocyte counts, primarily neutrophils, without affecting erythrocyte counts, haemoglobin, or haematocrit. Plasma biochemistry showed a slight decrease in glucose and increases in Na, Ca, Cu, Mg, and cholesterol, along with increased AST and ALT activities. Subchronic treatment resulted in a 15% increase in AST activity and a significant reduction in glutathione concentration of about 20%. Pathological effects included liver cellular degeneration, kidney glomeruli shrinkage, and medullary haemorrhage, though these were milder during the 28-day treatment.

The main side effects this plant can have are shown in the list below.

  • decreased plasma glucose concentration
  • increased alanine aminotransferase activity
  • medullary haemorrhage
  • monocellular infiltrations
  • reduced body weight
Evidence Level: ★★★☆☆

What herbs are paired with Avicennia marina?

This plant, Avicennia marina, is most frequently paired with herbs such as ginger, lemongrass, and peppermint in traditional medicinal applications.

These combinations are often utilized to create decoctions that target respiratory issues or skin inflammations. Lemongrass is frequently added to the mixture to enhance the antibacterial properties of the mangrove leaves. Ginger is integrated into these herbal blends to provide warming effects and aid in digestive relief.

When combined with peppermint, the mixture can offer a cooling sensation useful for topical treatments.

Evidence Level: ★☆☆☆☆